23.03.2021

AiCuris to participate BIO-Europe Spring panel “Pandemic therapeutics: treating COVID-19 and beyond”

AiCuris to participate BIO-Europe Spring panel

“Pandemic therapeutics: treating COVID-19 and beyond”

While vaccines have taken the limelight, the biotech industry has been working just as hard to develop therapeutic treatments for COVID-19. From innovative new treatments to repurposing well-known drugs, identifying, testing, and manufacturing safe and effective treatments still face the same high bar for approval as before the pandemic, only with the added urgency of immediate need. Hear from some of the companies at the center of this effort about their individual initiatives as well as the broader collaborations established to address the current pandemic and thinking ahead to the next.

Moderated by Alaric DeArment from Scrip, the panel will highlight the achievements in COVID-19 therapeutics development, discuss how the focus on vaccines overshadows drug development in this field and introduce collaborative initiatives that have been set up to address the issue, such as CARE and BEAT.

 

Title:     ‘COVID-19 therapeutics development’
Date and Time: March 25, 2021, 17:00-18:00 CET
Speaker: Dr. Holger Zimmermann, CEO
Attending: The discussion will be held on Zoom

 


back